[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354264-105":59,"doc-detail-354264-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","organ-specific-pre-metastatic-and-metastatic-niches-in-colorectal-cancer-discrepancy-in-response-to-immune-checkpoint-inhibitors-in-liver-and-lung-metastasis","Organ-specific pre-metastatic and metastatic niches in colorectal cancer - Discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis","","Colorectal cancer remains a major cause of cancer mortality driven by metastatic disease, where organ microenvironments shape both pre-metastatic niches and metastatic tumor microenvironments. Tumor-secreted factors such as extracellular vesicles, cytokines, and integrins remodel vasculature, suppress immunity, and reprogram stroma before tumor arrival. The liver forms a tolerogenic, immunosuppressive niche, while the lung shows a more inflammatory but neutrophil-dampened immune-reactive state. These differences associate liver metastasis with resistance to immune checkpoint inhibitors and lung metastasis with improved responses. ",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/organ-specific-pre-metastatic-and-metastatic-niches-in-colorectal-cancer-discrepancy-in-response-to-immune-checkpoint-inhibitors-in-liver-and-lung-metastasis/354264/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/organ-specific-pre-metastatic-and-metastatic-niches-in-colorectal-cancer-discrepancy-in-response-to-immune-checkpoint-inhibitors-in-liver-and-lung-metastasis/354264.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role do pre-metastatic niches play in colorectal cancer metastasis?","Question",{"text":113,"@type":114},"They are formed when tumor-derived factors precondition distant organs, shaping the microenvironment so metastatic tumors can later develop. This influences tumor progression, metastatic spread, and treatment response.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do the liver and lung immune landscapes differ in CRC?",{"text":118,"@type":114},"The liver develops a highly tolerogenic, immunosuppressive niche with myeloid accumulation and T-cell depletion, while the lung shows a more inflammatory, immune-reactive microenvironment with lymphocyte activation but concurrent neutrophil-driven immunosuppression.",{"name":120,"@type":111,"acceptedAnswer":121},"How do these organ differences affect immune checkpoint inhibitor outcomes?",{"text":122,"@type":114},"Liver metastasis is consistently associated with resistance to immune checkpoint inhibitors, whereas lung metastasis shows relatively improved responses. This reflects the distinct immune landscapes of each organ.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354264,1790143672,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Review  \nPUBLISHED 21 May 2026  \nDOI 10.3389/fimmu.2026.1838169  \nOPEN ACCESS  \nEDITED BY  \nDalit Barkan,  \nUniversity of Haifa, Israel  \nREVIEWED BY  \nAshley Pearson,  \nUniversity of Michigan, United States Yifan Feng,  \nThe First Afﬁliated Hospital of China Medical University, China  \n*CORRESPONDENCE  \nAli Shamseddine  \n [as04@aub.edu.lb](as04@aub.edu.lb)  \nRECEIVED 24 March 2026  \nREVISED 26 April 2026  \nACCEPTED 07 May 2026  \nPUBLISHED 21 May 2026  \nCITATION  \nMourad M, Al Mahmasani L, Abbas N and Shamseddine A (2026) Organ-speciﬁc pre-metastatic and metastatic niches in colorectal cancer: “discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis”. Front. Immunol. 17:1838169 .  \ndoi: 10.3389/fimmu.2026.1838169  \nCOPYRIGHT  \n© 2026 Mourad, Al Mahmasani, Abbas and Shamseddine. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nOrgan-speciﬁc pre-metastatic and metastatic niches in colorectal cancer: “discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis”  \nMohamad Mourad, Layal Al Mahmasani, Noura Abbas and Ali Shamseddine*  \nDepartment of Internal Medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon  \nColorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, largely driven by metastatic disease. Increasing evidence suggests that metastasis is dictated by tumor-secreted factors that shape the microenvironment of target organs leading to the formation of the pre-metastatic niche (PMN) and resultant metastatic niche and tumor microenvironment (TME) . Tumorderived factors, including extracellular vesicles, cytokines, and integrins, orchestrate vascular remodeling, immune suppression, and stromal reprogramming in distant organs prior to tumor cell arrival. While many of these processes are shared, the liver develops a highly tolerogenic and immunosuppressive niche characterized by myeloid cell accumulation, T-cell depletion, and systemic immune dampening. In contrast, the lung exhibits a more inﬂammatory and immune-reactive microenvironment, with enhanced lymphocyte activation but concurrent neutrophil-driven immunosuppression. These differences translate into clinically meaningful disparities in immunotherapy outcomes, with liver metastasis consistently associated with resistance to ICIs, whereas lung metastasis demonstrates relatively improved responses. This review examines the mechanisms underlying PMN formation in CRC, with a particular focus on the liver and lung, and explores how their distinct immune landscapes inﬂuence response to immune checkpoint inhibitors (ICIs) . It also evaluates the current therapeutic strategies aimed at overcoming organ-speciﬁc resistance, including combination immunotherapies, anti-angiogenic agents, targeted therapies, and TME-modulating approaches. Finally, we highlight key limitations in existing evidence and propose future directions, emphasizing the need for organ-speciﬁc therapeutic strategies and clinical trial designs. A deeper understanding of PMN biology and organ-dependent immune regulation may enable more effective, tailored treatments for metastatic CRC.  \nKEYWORDS  \ncolorectal cancer, immune checkpoint inhibitors, liver metastasis, lung metastasis, pre-metastatic niche, tumor microenvironment  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nGlobally, colorectal cancer (CRC) ranks third in incidence, with 1.9 million new cases annually, and is the second leading cause of cancer-related mortality with almost 900,00","cbCaidnqVDm3ish3","https://ap.wps.com/l/cbCaidnqVDm3ish3","pdf",1113774,14,"English","# Introduction\n## Organ-specific immune niches in colorectal cancer\n## Organ-dependent response to immune checkpoint inhibitors","[{\"question\":\"What role do pre-metastatic niches play in colorectal cancer metastasis?\",\"answer\":\"They are formed when tumor-derived factors precondition distant organs, shaping the microenvironment so metastatic tumors can later develop. This influences tumor progression, metastatic spread, and treatment response.\"},{\"question\":\"How do the liver and lung immune landscapes differ in CRC?\",\"answer\":\"The liver develops a highly tolerogenic, immunosuppressive niche with myeloid accumulation and T-cell depletion, while the lung shows a more inflammatory, immune-reactive microenvironment with lymphocyte activation but concurrent neutrophil-driven immunosuppression.\"},{\"question\":\"How do these organ differences affect immune checkpoint inhibitor outcomes?\",\"answer\":\"Liver metastasis is consistently associated with resistance to immune checkpoint inhibitors, whereas lung metastasis shows relatively improved responses. This reflects the distinct immune landscapes of each organ.\"}]","Organ-specific pre-metastatic and metastatic niches in colorectal cancer - Discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis | PDF",1790109768,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c638fed1bf1cefe6d58cfdc5f0de41dc.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9333bc125110d440d204184743a6bd74.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2efc5415134e210b2c394268b63b9f4a.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79bade45460109a52cf8d601b1ea22f9.webp",980,1385]